Epstein Secrets

tuart Evans Bob Every Dean Chief Executive Officer President and Chief Executive Officer Chief Executive Officer Chief Executive Officer Head, Pharma Division Chief Executive Officer, Asset Management Chairman, President and Chief Executive Officer Editor-in-Chief, Magazines Vice-President, Corporate

of the Board of Managing Directors Chief Executive Chief Executive Officer and Editor-in-Chief Clarence James Gamble Professor of Economics and Demography Chief Executive Officer Dean Deputy Managing Editor Founder and Chief Executive Officer Member of the Board, Chief Financial Officer and Chairm

Klaus Engel Chief Executive Officer Evonik Industries AG Germany Richard P. Eno Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland Mary Callahan Erdoes Chief Executive Officer, Asset JPMorgan Chase & Co. USA Management Charles W. Ergen Chairman, P

nnual Meeting 2011 EFTA_R1_02011048 EFTA02686173 David E. Bloom Clarence James Gamble Professor of Harvard School of Public USA Economics and Demography Health Kathy Bloomgarden Chief Executive Officer Ruder Finn Inc. USA Sally Blount Dean Kellogg School of USA Management Rebecca Blumenstei

Klaus Engel Chief Executive Officer Evonik Industries AG Germany Richard P. Eno Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland Mary Callahan Erdoes Chief Executive Officer, Asset JPMorgan Chase & Co. USA Management Charles W. Ergen Chairman, P

nnual Meeting 2011 EFTA_R1_02011167 EFTA02686250 David E. Bloom Clarence James Gamble Professor of Harvard School of Public USA Economics and Demography Health Kathy Bloomgarden Chief Executive Officer Ruder Finn Inc. USA Sally Blount Dean Kellogg School of USA Management Rebecca Blumenstei